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N-Glycanase deglycosylation of purified 44 kDa chymotryptic ollagen-binding domain from human plasma fibronectin 
does not significantly modify its behavior on gelatin affinity chromatography. This indicates that carbohydrates do not 
play any role in the binding affinity of fibronectin to collagen. The influence of changes in glycosylation on the biological 
functions of fibronectin is discussed. 
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1. INTRODUCTION 
Plasma fibronectin (pFn) is a high-Mr adhesive 
glycoprotein constituted of two similar subunits 
joined at the carboxy-terminal ends by disulfide 
bonds [ 11. pFn has been implicated in numerous 
biological phenomena including cellular adhesion 
and migration, embryonic differentiation, 
chemotaxis, wound healing and hemostasis. These 
functions are associated with the presence in the 
pFn molecule of different domains which bind a 
variety of macromolecules including cell mem- 
brane receptors [2], collagen [3], heparin and other 
glycosaminoglycans [4], fibrin [5] and actin [6]. 
The role of carbohydrate residues in these 
binding functions is not yet well understood. The 
results of Olden et al. [7], suggesting that the car- 
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bohydrate moiety of Fn of chicken embryo 
fibroblasts is not required for the mediation of a 
number of biological activities played by this 
glycoprotein, have been recently re-examined by 
Jones et al. [8]. These authors provide evidence 
that carbohydrates weaken the binding affinity of 
human cellular Fn to gelatin and cellular receptors. 
Here, we show that enzymatic deglycosylation of 
the pFn collagen-binding domain does not affect 
its affinity for denatured collagen. 
2. MATERIALS AND METHODS 
2.1. Reagents 
N-Glycanase [peptide :N-glycosidase F, peptide-N’-(N- 
acetyl-@glucosaminyl)asparaglne amidase, EC 3.5.1.521 
(260 U/ml) was purchased from Genzyme (Boston, MA). a- 
Chymotrypsin type II (EC 3.4.21.1) (48 Wmg) was from Sigma 
(St Louis, MO), [‘Z51]IMS.30 from Amersham (Amersham, 
England). Iodo-Gen (1,3,4,6-tetrachloro-3@,&-diphenyl- 
glycoluryl) was obtained from Pierce (Rockford, IL), gelatin- 
UItrogeI and Ultrogel AcA 44 from IBF (Villeneuve la G., 
France) and heparin-Sepharose 6B from Pharmacia (Uppsala). 
2.2. Purification of pFn and preparation of the chymottyptic 
coliagen-binding domain 
pFn was prepared from titrated human plasma by gelatin- 
Ultrogel affinity chromatography as described [3] and eluted by 
4 M urea. Prior to digestion, purified pFn was dialysed vs TBS. 
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Hydrolysis was performed with cY-chymotrypsin (pFn concen- 
tration, 0.8 m&ml; enzyme/substrate ratio, 1: 100, w/w) for 
3 h at 20°C [9]. The chymotryptic hydrolysate was applied to 
heparin-Sepharose 6B and gelatin-Ultrogel columns serially 
(both 3 ml bed volume) equilibrated in TBS. After washing, the 
gelatin-Ultrogel column was eluted with 6 M urea. 
2.3. Radioiodination 
The chymotryptic collagen-binding domain was radio- 
iodinated using [1251]IMS.30 by the Iodo-Gen method accor- 
ding to Fraker and Speck [lo]. ‘%labelled collagen-binding 
domain was further purified by gel permeation on an Ultrogel 
AcA 44 column (1.6 x 100 cm) equilibrated in TBS sup- 
plemented with BSA (1 mg/ml). 
2.4. Degiycosylation 
The 1251-labelled collagen-binding domain was deglycosylated 
with N-glycanase without previous denaturation. First, labelled 
glycopeptides were equilibrated in 0.22 M Tris-HCl (pH 8.6) 
buffer by gel permeation on a Sephadex G-25 column (10 ml 
bed volume). The reaction mixture containing, in a final volume 
of 90 pl, 80 ~1 glycopeptide solution (18000 cpm/lO hl), 9 ~1 of 
100 mM 1 , lO-phenanthroline hydrate (in methanol solution) 
and 1 ,uI enzyme solution, was incubated for 48 h at 37°C. The 
action of N-glycanase was analyzed by SDS-PAGE (5-25% 
gradient gel run under reducing conditions) and 
autoradiography [111. 
2.5, Gelatin affinity chromatography 
Native or deglycosylated collagen-binding fragments were ap- 
plied to a 10 ml gelatin-Ultrogel column and eluted with a 
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Fig. 1. SDS-PAGE of purified pFn stained with Coomassie blue 
(lane A) and of 1251-labelled native (B) and deglycosylated (C) 
collagen-binding fragments characterized by autoradiography. 
The left lane indicates the position of marker proteins for 
molecular mass estimation (in kDa); ferritin (220), 
phosphorylase b (94), albumin (67), ovalbumin (43), carbonic 
anhydrase (30), trypsin inhibitor (20.1) and cr-lactalbumin 
(14.4). 
400 ml linear gradient from 0 to 6 M urea in TBS, sup- 
plemented with 0.1 mM PMSF. 
3. RESULTS 
3.1. N-Glycanase treatment 
Affinity chromatography on heparin-Sepharose 
and gelatin-Ultrogel columns, followed by gel 
permeation on an Ultrogel AcA 44 column, led to 
isolation of the 44 kDa collagen-binding domain 
from the chymotryptic hydrolysate of purified 
pFn. Fig.1 shows SDS-PAGE of affinity-purified 
pFn and of its native and deglycosylated 
chymotryptic collagen-binding domains. Elec- 
trophoresis was run under reducing conditions and 
the absence of lower molecular mass bands in- 
dicates that there is no internal cleavage of the 
44 kDa glycopeptides. After N-glycanase treat- 
ment, we observed a shift of the apparent 
molecular mass by about 6 kDa. Given that the 
collagen-binding domain of pFn is substituted by 
three biantennary N-glycans [12] with an expected 
mass of 5800 Da, the shift can therefore be at- 
tributed to total deglycosylation of the fragment. 
3.2. Gelatin affinity chromatography 
Collagen-binding domains treated or not with 
N-glycanase quantitatively bound to the gelatin- 
Ultrogel column and the elution profiles obtained 
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Fig.2. Elution profiles of chymotryptic collagen-binding 
fragment from gelatin-Ultrogel column. Both fragments, native 
(o--O) or deglycosylated (e), were eluted with 400 ml of 
a O-6 M urea gradient. 3.35-ml fractions were collected. 
Elution peak of both fragments appeared at 2.95 M. (-) 
Urea concentration. 
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with a linear gradient of O-6 M urea are shown in 
fig.2. The peak for elution of the native 44 kDa 
collagen-binding domain appeared at 2.95 M urea. 
We could observe that the apparent affinity of the 
isolated domain is enhanced vs native pFn (not 
shown). There is no significant difference in the 
profile obtained with the deglycosylated fragment, 
eluted at the same concentration in urea. Ex- 
periments performed in duplicate after 2 or 6 days 
incubation with the enzyme gave identical results. 
4. DISCUSSION 
Most of the fibronectin carbohydrates are 
located on the gelatin-binding domain of the 
molecule and Bernard et al. [13] have clearly 
shown that they play an important role in the 
stabilization of this domain against proteolytic 
degradation. On the other hand, the role of car- 
bohydrates in the binding function is not yet well 
established and contradictory results have been 
reported [7,8]. Zhu and Laine [9] have recently 
shown that polylactosaminic glycosylation of 
human placental Fn weakens its affinity to gelatin. 
Here, we show that removal of biantennary 
glycans by N-glycanase does not affect the binding 
capacity of the collagen-binding domain of pFn. 
From these results, it appears that the binding 
capacity of Fns to collagenous structures can be 
modulated by the nature of the glycan. Several 
studies- report evidence that Fns glycans can be 
modified under physiological [14,15] or 
pathological conditions such as neoplastic 
transformation [ 16- 191. With this in mind, further 
work is needed to determine the effect of the 
enrichment in tri- and tetra-antennary glycans and 
of high sialylation on the binding capacity of Fns 
secreted by transformed cells. 
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